Do not take ALA (alpha-lipoic acid) for migraines- at least for now.
Posted on June 22 2022,
Alpha-Lipoic Acid or ALA is most commonly known for its use in patients with diabetic neuropathy.
In the most recent study evaluating ALA for migraines, it was found that "no significant changes were observed for NO levels and duration of migraine pains."
Moreover, ALA was found to reduce the lifespan of mice.
https://pubmed.ncbi.nlm.nih.gov/22785389/
Healthy mice treated long-term with ALA developed hepatic steatosis and liver injury. The effect of long-term ALA supplementation in humans is currently unknown and, therefore, it is possible that similar negative effects could be observed.
With the risk of shortening lifespan and causing injury, ALA is just not worth the risk especially with limited to no benefit.
Sat, Jun 14, 25
One FREE month of Neura Health
Get One Month Free with Neura Health Specialized headache care with no commitment LIMITED TIME OFFER CEREBRALTORQUE2025 Enter at app.neurahealth.co/onboarding(enter code CEREBRALTORQUE2025 when prompted) Your Free Month Includes: Care coaching...
Read MoreTue, Jun 10, 25
Acute Migraine Treatment
Complete evidence-based guide to acute migraine treatment for adults. Learn optimal dosing for triptans, NSAIDs, CGRP antagonists & emergency protocols. Includes treatment pearls, medication selection strategies, and prevention of medication...
Read MoreTue, Jun 10, 25
Vestibular Migraine
Comprehensive guide to vestibular migraine: symptoms, diagnosis, and evidence-based treatment options for migraine-related vertigo and dizziness. Learn about causes, triggers, medications, and long-term management strategies for this common but underdiagnosed...
Read More